Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria

European Cytokine Network

Volumn 17, Issue 3, 2006, Pages 175-180

  Kalmbach, Yvonne ^a,b   Boldt, Angelia B W ^a   Fendel, Rolf ^a,b   Mordmüller, Benjamin ^a,b   Kremsner, Peter G ^a,b   Kun, Jürgen F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Medical Research Unit   (Gabon)

Author keywords

CD85j; Cytokine; Malaria; MHC class I; Plasmodium falciparum

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; LIPOCORTIN 5;

ARTICLE; B LYMPHOCYTE; BLOOD; HUMAN; MALARIA FALCIPARUM; METABOLISM;

ANNEXIN A5; ANTIGENS, CD; B-LYMPHOCYTES; HUMANS; MALARIA, FALCIPARUM; RECEPTORS, IMMUNOLOGIC;

EID: 39049195758     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jüliger S, Bongartz M, Luty AJ, Kremsner PG, Kun JF. Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 2003; 54: 675.
2. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, Otchwemah RN, Dietz E, Ehrhardt S, Schroder NW, Bienzle U, Schumann RR. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci USA 2006; 103: 177.
3. Nakajima H, Asai A, Okada A, Ping L, Hamajima F, Sata T, Isobe K. Transcriptional regulation of ILT family receptors. J Immunol 2003; 171: 6611.
4. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359.
5. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217.
6. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, Trowsdale J. Plasticity in the organization and sequences of human KIR/ ILT gene families. Proc Natl Acad Sci USA 2000; 97: 4778.
7. Samaridis J, Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 1997; 27: 660.
8. Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsi V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, Simmons D, Uguccioni M, van der SE, Vivier E, Zola H. CD antigens 2001. Eur J Immunol 2001; 31: 2841.
9. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363.
10. Volz A, Wende H, Laun K, Ziegler A. Genesis of the ILT/LIR/MIR clusters within the human leukocyte receptor complex. Immunol Rev 2001; 181: 39.
11. Feldhahn N, Schwering I, Lee S,Wartenberg M, Klein F, Wang H, Zhou G, Wang SM, Rowley JD, Hescheler J, Kronke M, Rajewsky K, Kuppers R, Muschen M. Silencing of B cell receptor signals in human naive B cells. J Exp Med 2002; 196: 1291.
12. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997; 7: 273.
13. Bellon T, Kitzig F, Sayos J, Lopez-Botet M. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 2002; 168: 3351.
14. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996; 5: 629.
15. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 2001; 166: 3933.
16. Casado JG, Soto R, DelaRosa O, Peralbo E, Carmen Munoz-Villanueva M, Rioja L, Pena J, Solana R, Tarazona R. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother 2005; 54: 1162.
17. Ince MN, Harnisch B, Xu Z, Lee SK, Lange C, Moretta L, Lederman M, Lieberman J. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 2004; 112: 531.
18. Cigel F, Batchelder J, Burns Jr. JM, Yanez D. van der HH, Manning DD, Weidanz WP. Immunity to blood-stage murine malarial parasites is MHC class II dependent. Immunol Lett 2003; 89: 243.
19. Kuroki K, Tsuchiya N, Shiroishi M, Rasubala L, Yamashita Y, Matsuta K, Fukazawa T, Kusaoi M, Murakami Y, Takiguchi M, Juji T, Hashimoto H, Kohda D, Maenaka K, Tokunaga K. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum Mol Genet 2005; 14: 2469.
20. Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J Infect Dis 2005; 191: 1623.
21. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle U, Kremsner PG. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 1999; 28: 794.
22. Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner PG. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68: 3909.
23. Luty AJF, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbig K, Schmid D, Ulbert S, Migotabias F, Dubois B, Deloron P, Kremsner PG. Parasite antigen-specific IL-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum. Eur Cytokine Netw 1998; 9: 639.